Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions

Details for Australian Patent Application No. 2005270129 (hide)

Owner Bristol-Myers Squibb Company

Inventors Zhu, Yeheng; Riexinger, Douglas James; Ewing, William R.; Haque, Tasir S.; Martinez, Rogelio L.; Sulsky, Richard B.; Mapelli, Claudio; Lee, Ving G.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005270129

PCT Pub. Number WO2006/014287

Priority 60/585,358 02.07.04 US; 60/684,805 26.05.05 US

Filing date 2 January 2007

Wipo publication date 9 February 2006

International Classifications

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/014287 Priority application(s): WO2006/014287

23 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270131-Modified blackjack game

2005270124-Prodrugs of HIV protease inhibitors